Infection Control Market by Transmission (Airborne, Bloodborne, Contract), Products (Cleaning & Disinfection, Endoscope Reprocessing, Protective Barriers), End-User - Global Forecast 2024-2030


Attention: There is an updated edition available for this report.

Infection Control Market by Transmission (Airborne, Bloodborne, Contract), Products (Cleaning & Disinfection, Endoscope Reprocessing, Protective Barriers), End-User - Global Forecast 2024-2030


The Infection Control Market size was estimated at USD 43.62 billion in 2023 and expected to reach USD 45.80 billion in 2024, at a CAGR 5.23% to reach USD 62.37 billion by 2030.

Global Infection Control Market Infection control, which includes personal hygiene items, such as hand washing, disinfectant, and disposable paper, prevents the transmission of infections in hospital environments. Contamination caused by medical disposables on hospital surfaces is one of the significant reasons for disease transmission. Therefore, appropriate disinfection products are necessary to reduce exposure to bacterial infection. The rising number of healthcare-associated infections can lead to many illnesses among nursing facilities and patients, resulting in the surging usage of infection control products. However, some adverse health and skin problems caused by using disinfectants hamper the market growth. Moreover, increasing outsourcing of sterilization services in various industries to keep their facilities clean and infection is expected to create widespread adoption by end users.Regional InsightsThe infection control market shows a highly evolving landscape in the Americas owing to the established industrial sector and increasing application of infection control products in various sectors, including healthcare and food & beverages. The Ministry of Health in Singapore launched the Clean Hands, Save Lives campaign to promote hand hygiene among healthcare workers and the general public resulting in the high adoption of infection control products in the APAC region. Rising government support is a significant factor in launching infection prevention programs in the EMEA region. The European Center for Disease Control and Prevention (CDC) has shifted its focus to introduce standard precautions, including hand hygiene, appropriate use of personal protective equipment, and environmental measures such as cleaning and sterilization in healthcare settings. In Europe, researchers at the University of Nottingham have focused on discovering a new infection control product that prevents bacterial infections typically caused by biofilms on catheters is expected to have high adoption from healthcare facilities, thereby contributing to the market growth.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Infection Control Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Infection Control Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Infection Control Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, AliMed, Inc., Amway Corporation, Ansell Ltd., ASP International GmbH, Becton, Dickinson and Company, Belimed AG, bioMérieux SA, Cantel Medical Group, Cardinal Health Inc., Codi Group BV, Colgate-Palmolive Company, Dandong Huayang Textile and Garment Co., Ltd., Diversey Holdings Ltd., Ecolab Corporation, Embuer Health Pvt. Ltd., Essity AB, F. Hoffmann-La Roche Ltd., Getinge AB, Go Green Solutions, LLC, GOJO Industries, Inc., Hartmann Group, Jiaxing Hongjie Commodity Co., Ltd., Kao Corporation, Kimberly-Clark Corporation, Matachana Group, Medexter Healthcare, Medline Industries, LP, MELAG Medizintechnik GmbH & Co. KG, Merck KGaA, Metrex Research, LLC, Nice-Pak Products, Inc., Olympus Corporation, Pal International Ltd., Pfizer Inc., Procter & Gamble Company, Professional Disposables International, Inc., Reckitt Benckiser Group PLC, Rockline Industries Ltd., S. C. Johnson & Son, Inc., Sotera Health LLC, Sterigenics International LLC, Steris Corporation, Unicharm Corporation, Unilever PLC, Weiman Products, LLC, WipesPlus, World Precision Instruments, LLC, and Yessor Wipes.

Market Segmentation & Coverage

This research report categorizes the Infection Control Market to forecast the revenues and analyze trends in each of the following sub-markets:

Transmission
Airborne

Bloodborne

Contract

Products
Cleaning & Disinfection
Disinfectants
Hand Disinfectants

Instrument Disinfectants

Skin Disinfectants

Surface Disinfectants

Equipment
Flusher Disinfectors

Ultrasonic Cleaners

UV-Ray Disinfectors

Washer Disinfectors

Formulation
Disinfectant Sprays

Disinfectant Wipes

Liquid Disinfectants

Level of Disinfection
High-Level

Intermediate-Level

Low-Level

Endoscope Reprocessing
Consumables

Equipment

Protective Barriers
Covers & Closures

Goggles

Medical Nonwovens

Sterilization
E-Beam Sterilization

Equipment Sterilization

ETO Sterilization

Filtration Sterilization

Gamma Sterilization

Radiation Sterilization

Steam Sterilization

End-User
Food & Beverage Companies

Hospitals & Clinics

Life Sciences Industry

Medical Device Companies

Pharmaceutical Companies

Region
Americas
Argentina

Brazil

Canada

Mexico

United States
California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas

Asia-Pacific
Australia

China

India

Indonesia

Japan

Malaysia

Philippines

Singapore

South Korea

Taiwan

Thailand

Vietnam

Europe, Middle East & Africa
Denmark

Egypt

Finland

France

Germany

Israel

Italy

Netherlands

Nigeria

Norway

Poland

Qatar

Russia

Saudi Arabia

South Africa

Spain

Sweden

Switzerland

Turkey

United Arab Emirates

United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Infection Control Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Infection Control Market?
3. What are the technology trends and regulatory frameworks in the Infection Control Market?
4. What is the market share of the leading vendors in the Infection Control Market?
5. Which modes and strategic moves are suitable for entering the Infection Control Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Infection Control Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidence of hospital-acquired infections and surging usage of infection control products
5.1.1.2. Increasing number of surgical procedures and need for appropriate safety methods
5.1.1.3. Upsurging adoption of infection control products in medical device and pharmaceutical industry
5.1.2. Restraints
5.1.2.1. Adverse effects associated with chemical based disinfectants
5.1.3. Opportunities
5.1.3.1. Increasing outsourcing of sterilization services by hospitals, and clinics
5.1.3.2. Growing investments by manufacturers in the production of infection control products
5.1.4. Challenges
5.1.4.1. Availability of substitute products and techniques for infection control
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Infection Control Market, by Transmission
6.1. Introduction
6.2. Airborne
6.3. Bloodborne
6.4. Contract
7. Infection Control Market, by Products
7.1. Introduction
7.2. Cleaning & Disinfection
7.3.1. Disinfectants
7.3.2.1. Hand Disinfectants
7.3.2.2. Instrument Disinfectants
7.3.2.3. Skin Disinfectants
7.3.2.4. Surface Disinfectants
7.3.2. Equipment
7.3.3.1. Flusher Disinfectors
7.3.3.2. Ultrasonic Cleaners
7.3.3.3. UV-Ray Disinfectors
7.3.3.4. Washer Disinfectors
7.3.3. Formulation
7.3.4.1. Disinfectant Sprays
7.3.4.2. Disinfectant Wipes
7.3.4.3. Liquid Disinfectants
7.3.4. Level of Disinfection
7.3.5.1. High-Level
7.3.5.2. Intermediate-Level
7.3.5.3. Low-Level
7.3. Endoscope Reprocessing
7.4.1. Consumables
7.4.2. Equipment
7.4. Protective Barriers
7.5.1. Covers & Closures
7.5.2. Goggles
7.5.3. Medical Nonwovens
7.5. Sterilization
7.6.1. E-Beam Sterilization
7.6.2. Equipment Sterilization
7.6.3. ETO Sterilization
7.6.4. Filtration Sterilization
7.6.5. Gamma Sterilization
7.6.6. Radiation Sterilization
7.6.7. Steam Sterilization
8. Infection Control Market, by End-User
8.1. Introduction
8.2. Food & Beverage Companies
8.3. Hospitals & Clinics
8.4. Life Sciences Industry
8.5. Medical Device Companies
8.6. Pharmaceutical Companies
9. Americas Infection Control Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Infection Control Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.
10. South Korea
10.
11. Taiwan
10.
12. Thailand
10.
13. Vietnam
11. Europe, Middle East & Africa Infection Control Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.
10. Nigeria
11.
11. Norway
11.
12. Poland
11.
13. Qatar
11.
14. Russia
11.
15. Saudi Arabia
11.
16. South Africa
11.
17. Spain
11.
18. Sweden
11.
19. Switzerland
11.
20. Turkey
11.
21. United Arab Emirates
11.
22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
12.3.1. Merger & Acquisition
12.3.1.1. Diversey to be Acquired by Solenis for USD 4.6 Billion
12.3.1.2. Acquisition of Amity International
12.3.2. Agreement, Collaboration, & Partnership
12.3.2.1. Polymed partners with Paras Healthcare to focus on infection control
12.3.2.2. Eastern Health and BD Implement Innovative Solution with Goal of Reducing Consumption of Antibiotics and Other Medications
12.3.2.3. BD and Burjeel Medical City announce strategic partnership to drive healthcare innovation in the UAE
12.3.3. New Product Launch & Enhancement
12.3.3.1. The Home Depot and Ecolab Launch Ecolab Scientific Clean
12.3.3.2. New Cardinal Health surgical drape helps reduce surgical site contamination risk
12.3.4. Investment & Funding
12.3.4.1. COPH receives CDC funding for new infection control resource center
12.3.5. Award, Recognition, & Expansion
12.3.5.1. UNC awarded USD 3M for emerging pathogen preparedness and training
12.3.5.2. 3M to expand PPE production
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. 3M Company
13.1.2. Abbott Laboratories
13.1.3. AliMed, Inc.
13.1.4. Amway Corporation
13.1.5. Ansell Ltd.
13.1.6. ASP International GmbH
13.1.7. Becton, Dickinson and Company
13.1.8. Belimed AG
13.1.9. bioMérieux SA
13.1.
10. Cantel Medical Group
13.1.
11. Cardinal Health Inc.
13.1.
12. Codi Group BV
13.1.
13. Colgate-Palmolive Company
13.1.
14. Dandong Huayang Textile and Garment Co., Ltd.
13.1.
15. Diversey Holdings Ltd.
13.1.
16. Ecolab Corporation
13.1.
17. Embuer Health Pvt. Ltd.
13.1.
18. Essity AB
13.1.
19. F. Hoffmann-La Roche Ltd.
13.1.
20. Getinge AB
13.1.
21. Go Green Solutions, LLC
13.1.
22. GOJO Industries, Inc.
13.1.
23. Hartmann Group
13.1.
24. Jiaxing Hongjie Commodity Co., Ltd.
13.1.
25. Kao Corporation
13.1.
26. Kimberly-Clark Corporation
13.1.
27. Matachana Group
13.1.
28. Medexter Healthcare
13.1.
29. Medline Industries, LP
13.1.
30. MELAG Medizintechnik GmbH & Co. KG
13.1.
31. Merck KGaA
13.1.
32. Metrex Research, LLC
13.1.
33. Nice-Pak Products, Inc.
13.1.
34. Olympus Corporation
13.1.
35. Pal International Ltd.
13.1.
36. Pfizer Inc.
13.1.
37. Procter & Gamble Company
13.1.
38. Professional Disposables International, Inc.
13.1.
39. Reckitt Benckiser Group PLC
13.1.
40. Rockline Industries Ltd.
13.1.
41. S. C. Johnson & Son, Inc.
13.1.
42. Sotera Health LLC
13.1.
43. Sterigenics International LLC
13.1.
44. Steris Corporation
13.1.
45. Unicharm Corporation
13.1.
46. Unilever PLC
13.1.
47. Weiman Products, LLC
13.1.
48. WipesPlus
13.1.
49. World Precision Instruments, LLC
13.1.
50. Yessor Wipes
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
FIGURE 1. INFECTION CONTROL MARKET RESEARCH PROCESS
FIGURE 2. INFECTION CONTROL MARKET SIZE, 2023 VS 2030
FIGURE 3. INFECTION CONTROL MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. INFECTION CONTROL MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. INFECTION CONTROL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. INFECTION CONTROL MARKET DYNAMICS
FIGURE 7. INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2023 VS 2030 (%)
FIGURE 8. INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2023 VS 2030 (%)
FIGURE 10. INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. INFECTION CONTROL MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. INFECTION CONTROL MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES INFECTION CONTROL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES INFECTION CONTROL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. INFECTION CONTROL MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. INFECTION CONTROL MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings